Dikla Czaczkes Akselbrad

2 weeks ago | infectioncontroltoday.com | Tori Whitacre Martonicz |Dikla Czaczkes Akselbrad

As surgical site infections (SSIs) begin to rise again across health care systems, traditional prevention strategies are being tested and often found wanting. Dikla Czaczkes Akselbrad, the chief executive officer of PolyPid, believes it is time for a paradigm shift. In a candid interview with Infection Control Today®(ICT®), Akselbrad outlines the critical role localized drug delivery can play in closing the gap between perioperative protocols and real-world outcomes.